Nuveen Asset Management LLC Buys 15,550 Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Nuveen Asset Management LLC raised its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 2.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 547,140 shares of the company's stock after purchasing an additional 15,550 shares during the quarter. Nuveen Asset Management LLC owned approximately 0.86% of Guardian Pharmacy Services worth $11,085,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the business. Charles Schwab Investment Management Inc. purchased a new stake in shares of Guardian Pharmacy Services in the fourth quarter worth about $544,000. Rhumbline Advisers purchased a new stake in shares of Guardian Pharmacy Services in the fourth quarter worth about $149,000. Northern Trust Corp purchased a new stake in shares of Guardian Pharmacy Services in the fourth quarter worth about $1,479,000. New York State Common Retirement Fund lifted its holdings in shares of Guardian Pharmacy Services by 17.9% in the fourth quarter. New York State Common Retirement Fund now owns 278,548 shares of the company's stock worth $5,643,000 after buying an additional 42,368 shares in the last quarter. Finally, Wells Fargo & Company MN lifted its holdings in shares of Guardian Pharmacy Services by 353.7% in the fourth quarter. Wells Fargo & Company MN now owns 6,715 shares of the company's stock worth $136,000 after buying an additional 5,235 shares in the last quarter.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on GRDN. Wall Street Zen downgraded shares of Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Raymond James set a $28.00 target price on shares of Guardian Pharmacy Services and gave the company an "outperform" rating in a research note on Wednesday, May 14th. Finally, Truist Financial reaffirmed a "buy" rating and issued a $28.00 target price (up from $25.00) on shares of Guardian Pharmacy Services in a research note on Monday, May 19th.

Insider Transactions at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director William E. Bindley sold 651,454 shares of the business's stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total value of $13,133,312.64. Following the completion of the transaction, the director now owns 1,939,817 shares of the company's stock, valued at approximately $39,106,710.72. The trade was a 25.14% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider David K. Morris sold 369,212 shares of the business's stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $20.16, for a total value of $7,443,313.92. Following the sale, the insider now owns 283,042 shares of the company's stock, valued at approximately $5,706,126.72. This represents a 56.61% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,344,912 shares of company stock valued at $228,713,426 in the last quarter. 63.71% of the stock is owned by insiders.

Guardian Pharmacy Services Stock Down 0.5%

NYSE GRDN traded down $0.10 on Friday, reaching $21.29. 481,223 shares of the company's stock traded hands, compared to its average volume of 168,263. Guardian Pharmacy Services, Inc. has a 12 month low of $14.16 and a 12 month high of $26.91. The stock has a 50-day simple moving average of $23.16 and a 200 day simple moving average of $22.01.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The company had revenue of $329.31 million during the quarter, compared to the consensus estimate of $321.21 million. As a group, analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.